Ferrandiz C, de la Cueva Dobao P, Simpson EL, Zhang R, Gadkari A, Eckert L, Akinlade B, Ardeleanu M. Dupilumab in Moderate-to-Severe Atopic Dermatitis: Pooled Efficacy Results from Two Identically Designed Randomized Phase 3 Trials (SOLO 1 & 2). J of Skin [Internet]. 2017 Oct. 27 [cited 2024 Jul. 4];1(3.1):s38. Available from: https://jofskin.org/33014/index.php/skin/article/view/201